ABNORMAL PATTERN OF POST-GAMMA-RAY DNA-REPLICATION IN RADIORESISTANT FIBROBLAST STRAINS FROM AFFECTED MEMBERS OF A CANCER-PRONE FAMILY WITHLI-FRAUMENI SYNDROME
R. Mirzayans et al., ABNORMAL PATTERN OF POST-GAMMA-RAY DNA-REPLICATION IN RADIORESISTANT FIBROBLAST STRAINS FROM AFFECTED MEMBERS OF A CANCER-PRONE FAMILY WITHLI-FRAUMENI SYNDROME, British Journal of Cancer, 71(6), 1995, pp. 1221-1230
Non-malignant dermal fibroblast strains, cultured from affected member
s of a Li-Fraumeni syndrome (LFS) family with diverse neoplasms associ
ated with radiation exposure, display a unique increased resistance to
the lethal effects of gamma-radiation. In the studies reported here,
this radioresistance (RR) trait has been found to correlate strongly w
ith an abnormal pattern of post-gamma-ray DNA replicative synthesis, a
s monitored by radiolabelled thymidine incorporation and S-phase cell
autoradiography. In particular, the time interval between the gamma-ra
y-induced shutdown of DNA synthesis and its subsequent recovery was gr
eater in all four RR strains examined and the post-recovery replicatio
n rate was much higher and was maintained longer than in normal and sp
ousal controls. Alkaline sucrose sedimentation profiles of pulse-label
led cellular DNA indicated that the unusual pattern of DNA replication
in irradiated RR strains may be ascribed to anomalies in both replico
n initiation and DNA chain elongation processes. Moreover, the RR stra
in which had previously displayed the highest post-gamma-ray clonogeni
c survival was found to harbour a somatic (codon 234) mutation (presum
ably acquired during culture in vitro) in the same conserved region of
the p53 tumour-suppressor gene as the germline (codon 245) mutation i
n the remaining three RR strains from other family members, thus coupl
ing the RR phenotype and abnormal post-gamma-ray DNA synthesis pattern
with faulty p53 expression. Significantly, these two aberrant radiore
sponse end points, along with documented anomalies in c-myc and c-raf-
1 proto-oncogenes, are unprecedented among other LFS families carrying
p53 germline mutations. We thus speculate that this peculiar cancer-p
rone family may possess in its germ line a second, as yet unidentified
, genetic defect in addition to the p53 mutation.